Screener
Amneal Pharmaceuticals, Inc. AMRX Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $127,637 | $282,029 |
| Restricted cash | 8,643 | 28,842 |
| Trade accounts receivable, net | 1,020,360 | 895,143 |
| Inventories | 677,954 | 606,302 |
| Prepaid expenses and other current assets | 112,011 | 98,395 |
| Related party receivables | 424 | 470 |
| Total current assets | 1,947,029 | 1,911,181 |
| Property, plant and equipment, net | 456,877 | 442,950 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s inventories?
- Amneal Pharmaceuticals, Inc. (AMRX) reported inventories of $677.95M in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s inventories changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s inventories increased by 11.3% year-over-year, from $608.97M to $677.95M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s inventories?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s inventories has grown at a 4.3% compound annual growth rate (CAGR), from $490.65M to $606.3M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Amneal Pharmaceuticals, Inc.'s inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude